Micro-RNA Profiling in CD4+ T Cell Differentiation.

Arnob Banerjee(Johnson & Johnson (United States)), Steven L. Reiner(Columbia University Irving Medical Center), Felix Schambach(The Wistar Institute), Scott M. Hammond(University of North Carolina at Chapel Hill)

Blood

November 16, 2006

10.1182/blood.v108.11.3887.3887

Cited by 0

Related Papers

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

|The Lancet|2021|1.7k

Teclistamab in Relapsed or Refractory Multiple Myeloma

|New England Journal of Medicine|2022|1.2k

Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responses

|Science|2007|852

Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing

|RNA|2008|678

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

|Journal of Clinical Oncology|2022|647